{"id":5657,"date":"2024-02-14T06:05:08","date_gmt":"2024-02-14T12:05:08","guid":{"rendered":"https:\/\/nanostherapeutics.com\/?p=5657"},"modified":"2025-06-27T11:21:28","modified_gmt":"2025-06-27T16:21:28","slug":"nanoscope-to-moderate-discussions-at-the-4th-annual-gene-therapy-comparability-summit","status":"publish","type":"post","link":"https:\/\/nanostherapeutics.com\/ja\/2024\/02\/14\/nanoscope-to-moderate-discussions-at-the-4th-annual-gene-therapy-comparability-summit\/","title":{"rendered":"\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u3001\u7b2c 4 \u56de\u907a\u4f1d\u5b50\u6cbb\u7642\u6bd4\u8f03\u30b5\u30df\u30c3\u30c8\u3067\u8b70\u8ad6\u3092\u53f8\u4f1a"},"content":{"rendered":"<div class=\"col-sm-8 col-vcenter col-xs-12\">\n<div class=\"col-sm-8 col-vcenter col-xs-12\">\n<h1><\/h1>\n<\/div>\n<\/div>\n<article class=\"news-release inline-gallery-template\">\n<section class=\"release-body container\">\n<div class=\"row\">\n<div class=\"col-lg-10 col-lg-offset-1\">\n<p><strong>\u30c0\u30e9\u30b9 <\/strong>2024 \u5e74 2 \u6708 14 \u65e5 \u2014 <a href=\"https:\/\/nanostherapeutics.com\/ja\/\">\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9\u793e<\/a>\u306f\u3001\u907a\u4f1d\u6027\u7db2\u819c\u75be\u60a3\u306e\u907a\u4f1d\u5b50\u6cbb\u7642\u3092\u958b\u767a\u3059\u308b\u81e8\u5e8a\u6bb5\u968e\u306e\u30d0\u30a4\u30aa\u30c6\u30af\u30ce\u30ed\u30b8\u30fc\u4f01\u696d\u3067\u3042\u308a\u3001\u7b2c 4 \u56de\u56fd\u969b\u4f1a\u8b70\u3067\u305d\u306e\u5f79\u5272\u3092\u767a\u8868\u3067\u304d\u308b\u3053\u3068\u3092\u3046\u308c\u3057\u304f\u601d\u3044\u307e\u3059\u3002 <a href=\"https:\/\/genetherapy-comparability.com\/\">\u5e74\u6b21\u907a\u4f1d\u5b50\u6cbb\u7642\u6bd4\u8f03\u30b5\u30df\u30c3\u30c8<\/a> 2024\u5e742\u670813\u65e5\u304b\u308915\u65e5\u307e\u3067\u30dc\u30b9\u30c8\u30f3\u3067\u958b\u50ac\u3055\u308c\u307e\u3059\u3002\u4eca\u5e74\u306e\u30b5\u30df\u30c3\u30c8\u306f\u3001\u6226\u7565\u7684\u304a\u3088\u3073\u6280\u8853\u7684\u30cf\u30fc\u30c9\u30eb\u3092\u514b\u670d\u3057\u3001\u65b0\u3057\u3044\u907a\u4f1d\u5b50\u6cbb\u7642\u306e\u627f\u8a8d\u3092\u4fc3\u9032\u3059\u308b\u305f\u3081\u306e\u52b9\u679c\u7684\u306a\u6bd4\u8f03\u7814\u7a76\u306e\u5b9f\u65bd\u306b\u7126\u70b9\u3092\u5f53\u3066\u308b\u3002<\/p>\n<p>Nanoscope\u793e\u306e\u793e\u9577\u517c\u6700\u9ad8\u79d1\u5b66\u8cac\u4efb\u8005\u3067\u3042\u308b\u30b5\u30de\u30ec\u30f3\u30c9\u30e9\u30fb\u30e2\u30cf\u30f3\u30c6\u30a3\u535a\u58eb\u304c\u30a4\u30d9\u30f3\u30c8\u306e\u8b70\u9577\u3092\u52d9\u3081\u307e\u3059\u3002\u30e2\u30cf\u30f3\u30c6\u30a3\u535a\u58eb\u306f\u30d7\u30ec\u30bc\u30f3\u30c6\u30fc\u30b7\u30e7\u30f3\u3068\u30bb\u30c3\u30b7\u30e7\u30f3\u3067\u3001\u6bd4\u8f03\u53ef\u80fd\u6027\u3092\u78ba\u4fdd\u3057\u306a\u304c\u3089\u5546\u696d\u7684\u306b\u5b9f\u884c\u53ef\u80fd\u306a\u30d7\u30ed\u30bb\u30b9\u306b\u79fb\u884c\u3059\u308b\u969b\u306e\u30d7\u30ed\u30bb\u30b9\u4fee\u6b63\u3068\u5148\u9032\u7684\u306a\u6226\u7565\u3092\u30ca\u30d3\u30b2\u30fc\u30c8\u3059\u308b\u305f\u3081\u306e\u6d1e\u5bdf\u3092\u63d0\u4f9b\u3057\u307e\u3059\u3002<\/p>\n<p><strong>\u30d7\u30ec\u30bc\u30f3\u30c6\u30fc\u30b7\u30e7\u30f3\u306e\u8a73\u7d30\u306f\u4ee5\u4e0b\u306e\u3068\u304a\u308a\u3067\u3059\u3002<br \/>\n<\/strong><strong>\u30bb\u30c3\u30b7\u30e7\u30f3\uff1a <\/strong>\u6bd4\u8f03\u53ef\u80fd\u6027\u3092\u652f\u63f4\u3059\u308b\u907a\u4f1d\u5b50\u6cbb\u7642\u30d7\u30ed\u30bb\u30b9\u958b\u767a\u306e\u9769\u65b0<br \/>\n<strong>\u30bf\u30a4\u30c8\u30eb\uff1a<\/strong> \u56f2\u7089\u88cf\u30c1\u30e3\u30c3\u30c8: \u907a\u4f1d\u5b50\u6cbb\u7642\u306e\u6bd4\u8f03\u53ef\u80fd\u6027\u306b\u304a\u3051\u308b\u8ab2\u984c\u3092\u6700\u5c0f\u9650\u306b\u6291\u3048\u308b\u305f\u3081\u306e\u30d7\u30ed\u30bb\u30b9\u5909\u66f4\u306e\u5bfe\u51e6\u3068\u5305\u62ec\u7684\u306a\u691c\u67fb\u306e\u4fdd\u8a3c<br \/>\n<strong>\u65e5\u4ed8\uff1a<\/strong> 2024\u5e742\u670814\u65e5\u6c34\u66dc\u65e5<br \/>\n<strong>\u6642\u9593\uff1a<\/strong> \u5348\u5f8c 3 \u6642 30 \u5206\uff08\u6771\u90e8\u6a19\u6e96\u6642\uff09<\/p>\n<p><strong>\u30bb\u30c3\u30b7\u30e7\u30f3\uff1a<\/strong> \u6bd4\u8f03\u53ef\u80fd\u6027\u306e\u554f\u984c\u3092\u514b\u670d\u3059\u308b\u305f\u3081\u306e\u5206\u6790\u4e0a\u306e\u8ab2\u984c\u3092\u6398\u308a\u4e0b\u3052\u308b<br \/>\n<strong>\u30bf\u30a4\u30c8\u30eb\uff1a<\/strong> CMC \u30d1\u30c3\u30b1\u30fc\u30b8\u306e\u63d0\u51fa\u306b\u304a\u3051\u308b\u8ab2\u984c\u3092\u89e3\u6c7a\u3059\u308b<br \/>\n<strong>\u65e5\u4ed8\uff1a<\/strong> 2024\u5e742\u670815\u65e5\uff08\u6728\uff09<br \/>\n<strong>\u6642\u9593\uff1a<\/strong> \u5348\u524d11\u664230\u5206\uff08\u6771\u90e8\u6a19\u6e96\u6642\uff09<\/p>\n<p>\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u306f\u3001\u60a3\u8005\u306e\u8ee2\u5e30\u3092\u5411\u4e0a\u3055\u305b\u308b\u305f\u3081\u306b\u907a\u4f1d\u5b50\u6cbb\u7642\u306e\u9650\u754c\u3092\u62bc\u3057\u4e0a\u3052\u308b\u3053\u3068\u306b\u5f15\u304d\u7d9a\u304d\u53d6\u308a\u7d44\u3093\u3067\u304a\u308a\u3001\u3053\u306e\u4f1a\u8b70\u3067\u5c0a\u656c\u3055\u308c\u308b\u540c\u50da\u3068\u306e\u523a\u6fc0\u7684\u306a\u8b70\u8ad6\u304c\u671f\u5f85\u3055\u308c\u3066\u3044\u307e\u3059\u3002<\/p>\n<p>\u8a73\u7d30\u3068\u767b\u9332\u306b\u3064\u3044\u3066\u306f\u3001\u6b21\u306e\u30b5\u30a4\u30c8\u3092\u3054\u89a7\u304f\u3060\u3055\u3044\u3002 <a href=\"https:\/\/genetherapy-comparability.com\/\">https:\/\/genetherapy-comparability.com\/<\/a><\/p>\n<p><strong>\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9\u793e\u306b\u3064\u3044\u3066<br \/>\n<\/strong>Nanoscope Therapeutics \u306f\u3001\u6cbb\u7642\u6cd5\u304c\u5b58\u5728\u3057\u306a\u3044\u907a\u4f1d\u6027\u7db2\u819c\u75be\u60a3\u306b\u3088\u3063\u3066\u5931\u660e\u3057\u305f\u4f55\u767e\u4e07\u4eba\u3082\u306e\u60a3\u8005\u3092\u5bfe\u8c61\u306b\u3001\u907a\u4f1d\u5b50\u306b\u4f9d\u5b58\u305b\u305a\u8996\u529b\u3092\u56de\u5fa9\u3059\u308b\u5149\u907a\u4f1d\u5b66\u7684\u6cbb\u7642\u6cd5\u3092\u958b\u767a\u3057\u3066\u3044\u307e\u3059\u3002\u540c\u793e\u306e\u4e3b\u529b\u8cc7\u7523\u3067\u3042\u308b MCO-010 \u306f\u3001\u7c73\u56fd\u3067\u7db2\u819c\u8272\u7d20\u5909\u6027\u75c7\u3092\u5bfe\u8c61\u3068\u3057\u305f RESTORE \u7b2c 2b \u76f8\u591a\u65bd\u8a2d\u7121\u4f5c\u70ba\u5316\u4e8c\u91cd\u30de\u30b9\u30af\u507d\u5bfe\u7167\u81e8\u5e8a\u8a66\u9a13\u306e\u30c8\u30c3\u30d7\u30e9\u30a4\u30f3\u7d50\u679c\u3092\u6700\u8fd1\u5831\u544a\u3057\u307e\u3057\u305f (<a href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04945772?term=Nanoscope&draw=2\">NCT04945772<\/a>\uff09\u3002\u540c\u793e\u306f\u6700\u8fd1\u3001\u30b7\u30e5\u30bf\u30eb\u30ac\u30eb\u30c8\u75c5\u60a3\u8005\u3092\u5bfe\u8c61\u3068\u3057\u305f MCO-010 \u7642\u6cd5\u306e\u7b2c 2 \u76f8 STARLIGHT \u8a66\u9a13\u3082\u5b8c\u4e86\u3057\u307e\u3057\u305f (<a href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT05417126?term=nanoscope&draw=2&rank=3\">NCT05417126<\/a>\uff09\u3002 MCO-010\u306f\u3001\u7db2\u819c\u8272\u7d20\u5909\u6027\u75c7\u3068\u30b7\u30e5\u30bf\u30eb\u30ac\u30eb\u30c8\u306e\u4e21\u65b9\u306b\u5bfe\u3057\u3066FDA\u30d5\u30a1\u30b9\u30c8\u30c8\u30e9\u30c3\u30af\u6307\u5b9a\u304a\u3088\u3073FDA\u5e0c\u5c11\u75be\u75c5\u7528\u533b\u85ac\u54c1\u6307\u5b9a\u3092\u53d7\u3051\u3066\u3044\u307e\u3059\u3002\u524d\u81e8\u5e8a\u8cc7\u7523\u306b\u306f\u3001\u5730\u7406\u7684\u840e\u7e2e\u306b\u5bfe\u3059\u308b\u975e\u30a6\u30a4\u30eb\u30b9\u30ec\u30fc\u30b6\u30fc\u306b\u3088\u308b MCO-020 \u907a\u4f1d\u5b50\u6cbb\u7642\u304c\u542b\u307e\u308c\u307e\u3059\u3002<\/p>\n<p><strong>\u6295\u8cc7\u5bb6\u9023\u7d61\u5148:<\/strong><br \/>\n\u30a2\u30eb\u30b4\u30c3\u30c8\u30d1\u30fc\u30c8\u30ca\u30fc\u30ba<br \/>\n212-600-1902<br \/>\n<a href=\"mailto:PR@nanostherapeutics.com\">PR@nanostherapeutics.com<\/a><\/p>\n<\/div>\n<\/div>\n<\/section>\n<\/article>","protected":false},"excerpt":{"rendered":"<p>Dallas, February 14, 2024 \u2014 Nanoscope Therapeutics, Inc., a clinical-stage biotechnology company developing gene therapies for inherited retinal diseases, is pleased to announce its role at the 4th Annual Gene Therapy Comparability Summit taking place February 13-15, 2024, in Boston. This year\u2019s summit will focus on implementing effective comparability studies to overcome strategic and technical hurdles and expedite the approvals of novel gene therapies. Samarendra Mohanty, PhD, President and Chief Scientific Officer of Nanoscope, will chair the event. In his presentation and in a session, Dr. Mohanty will offer insights into navigating process modifications and forward-thinking strategies in transitioning to commercially viable processes while ensuring comparability. Presentation details are as [&hellip;]<\/p>\n","protected":false},"author":6,"featured_media":5660,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_exactmetrics_skip_tracking":false,"_exactmetrics_sitenote_active":false,"_exactmetrics_sitenote_note":"","_exactmetrics_sitenote_category":0,"footnotes":"","_links_to":"","_links_to_target":""},"categories":[13,8],"tags":[],"class_list":["post-5657","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-home-page","category-nanoscope-press-release"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Nanoscope to Moderate Discussions at the 4th Annual Gene Therapy Comparability Summit - Nanoscope Therapeutics<\/title>\n<meta name=\"description\" content=\"Our multi-characteristic opsin (MCO) platform is the first to demonstrate an ability to restore vision to retinal disease patients with severe vision loss in clincial trials. Nanoscope has developed MCO-010, the first and only broad spectrum, fast response and ultra-sensitive optogenetic technology for vision restoration that is gene-agnostic.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/nanostherapeutics.com\/ja\/2024\/02\/14\/nanoscope-to-moderate-discussions-at-the-4th-annual-gene-therapy-comparability-summit\/\" \/>\n<meta property=\"og:locale\" content=\"ja_JP\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Nanoscope to Moderate Discussions at the 4th Annual Gene Therapy Comparability Summit - Nanoscope Therapeutics\" \/>\n<meta property=\"og:description\" content=\"Our multi-characteristic opsin (MCO) platform is the first to demonstrate an ability to restore vision to retinal disease patients with severe vision loss in clincial trials. Nanoscope has developed MCO-010, the first and only broad spectrum, fast response and ultra-sensitive optogenetic technology for vision restoration that is gene-agnostic.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/nanostherapeutics.com\/ja\/2024\/02\/14\/nanoscope-to-moderate-discussions-at-the-4th-annual-gene-therapy-comparability-summit\/\" \/>\n<meta property=\"og:site_name\" content=\"Nanoscope Therapeutics\" \/>\n<meta property=\"article:published_time\" content=\"2024-02-14T12:05:08+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-06-27T16:21:28+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2024\/02\/NSCOPE_LI_GeneTherapyComparability.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"1200\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Nanoscope Therapeutics\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:image\" content=\"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2024\/02\/NSCOPE_LI_GeneTherapyComparability.jpg\" \/>\n<meta name=\"twitter:creator\" content=\"@NSTherapeutics\" \/>\n<meta name=\"twitter:site\" content=\"@NSTherapeutics\" \/>\n<meta name=\"twitter:label1\" content=\"\u57f7\u7b46\u8005\" \/>\n\t<meta name=\"twitter:data1\" content=\"Nanoscope Therapeutics\" \/>\n\t<meta name=\"twitter:label2\" content=\"\u63a8\u5b9a\u8aad\u307f\u53d6\u308a\u6642\u9593\" \/>\n\t<meta name=\"twitter:data2\" content=\"2\u5206\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2024\\\/02\\\/14\\\/nanoscope-to-moderate-discussions-at-the-4th-annual-gene-therapy-comparability-summit\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2024\\\/02\\\/14\\\/nanoscope-to-moderate-discussions-at-the-4th-annual-gene-therapy-comparability-summit\\\/\"},\"author\":{\"name\":\"Nanoscope Therapeutics\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#\\\/schema\\\/person\\\/5aeedc9aef0946fe8f96f98f7b1808a2\"},\"headline\":\"Nanoscope to Moderate Discussions at the 4th Annual Gene Therapy Comparability Summit\",\"datePublished\":\"2024-02-14T12:05:08+00:00\",\"dateModified\":\"2025-06-27T16:21:28+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2024\\\/02\\\/14\\\/nanoscope-to-moderate-discussions-at-the-4th-annual-gene-therapy-comparability-summit\\\/\"},\"wordCount\":327,\"publisher\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2024\\\/02\\\/14\\\/nanoscope-to-moderate-discussions-at-the-4th-annual-gene-therapy-comparability-summit\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/nanostherapeutics.com\\\/wp-content\\\/uploads\\\/2024\\\/02\\\/NSCOPE_LI_GeneTherapyComparability.jpg\",\"articleSection\":[\"Home Page\",\"Nanoscope Press Release\"],\"inLanguage\":\"ja\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2024\\\/02\\\/14\\\/nanoscope-to-moderate-discussions-at-the-4th-annual-gene-therapy-comparability-summit\\\/\",\"url\":\"https:\\\/\\\/nanostherapeutics.com\\\/2024\\\/02\\\/14\\\/nanoscope-to-moderate-discussions-at-the-4th-annual-gene-therapy-comparability-summit\\\/\",\"name\":\"Nanoscope to Moderate Discussions at the 4th Annual Gene Therapy Comparability Summit - Nanoscope Therapeutics\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2024\\\/02\\\/14\\\/nanoscope-to-moderate-discussions-at-the-4th-annual-gene-therapy-comparability-summit\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2024\\\/02\\\/14\\\/nanoscope-to-moderate-discussions-at-the-4th-annual-gene-therapy-comparability-summit\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/nanostherapeutics.com\\\/wp-content\\\/uploads\\\/2024\\\/02\\\/NSCOPE_LI_GeneTherapyComparability.jpg\",\"datePublished\":\"2024-02-14T12:05:08+00:00\",\"dateModified\":\"2025-06-27T16:21:28+00:00\",\"description\":\"Our multi-characteristic opsin (MCO) platform is the first to demonstrate an ability to restore vision to retinal disease patients with severe vision loss in clincial trials. Nanoscope has developed MCO-010, the first and only broad spectrum, fast response and ultra-sensitive optogenetic technology for vision restoration that is gene-agnostic.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2024\\\/02\\\/14\\\/nanoscope-to-moderate-discussions-at-the-4th-annual-gene-therapy-comparability-summit\\\/#breadcrumb\"},\"inLanguage\":\"ja\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/nanostherapeutics.com\\\/2024\\\/02\\\/14\\\/nanoscope-to-moderate-discussions-at-the-4th-annual-gene-therapy-comparability-summit\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"ja\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2024\\\/02\\\/14\\\/nanoscope-to-moderate-discussions-at-the-4th-annual-gene-therapy-comparability-summit\\\/#primaryimage\",\"url\":\"https:\\\/\\\/nanostherapeutics.com\\\/wp-content\\\/uploads\\\/2024\\\/02\\\/NSCOPE_LI_GeneTherapyComparability.jpg\",\"contentUrl\":\"https:\\\/\\\/nanostherapeutics.com\\\/wp-content\\\/uploads\\\/2024\\\/02\\\/NSCOPE_LI_GeneTherapyComparability.jpg\",\"width\":1200,\"height\":1200},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2024\\\/02\\\/14\\\/nanoscope-to-moderate-discussions-at-the-4th-annual-gene-therapy-comparability-summit\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/nanostherapeutics.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Nanoscope to Moderate Discussions at the 4th Annual Gene Therapy Comparability Summit\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#website\",\"url\":\"https:\\\/\\\/nanostherapeutics.com\\\/\",\"name\":\"Nanoscope Therapeutics\",\"description\":\"Bringing Back the Light of Hope\",\"publisher\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#organization\"},\"alternateName\":\"Nanoscope Therapeutics\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/nanostherapeutics.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"ja\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#organization\",\"name\":\"Nanoscope Therapeutics, Inc\",\"alternateName\":\"Nanoscope Therapeutics\",\"url\":\"https:\\\/\\\/nanostherapeutics.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ja\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/nanostherapeutics.com\\\/wp-content\\\/uploads\\\/2025\\\/03\\\/NSCOPE_Logo_Stack_2Color_512.png\",\"contentUrl\":\"https:\\\/\\\/nanostherapeutics.com\\\/wp-content\\\/uploads\\\/2025\\\/03\\\/NSCOPE_Logo_Stack_2Color_512.png\",\"width\":512,\"height\":435,\"caption\":\"Nanoscope Therapeutics, Inc\"},\"image\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/x.com\\\/NSTherapeutics\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/nanoscope\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#\\\/schema\\\/person\\\/5aeedc9aef0946fe8f96f98f7b1808a2\",\"name\":\"Nanoscope Therapeutics\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u793e\u3001\u7b2c4\u56de\u907a\u4f1d\u5b50\u6cbb\u7642\u6bd4\u8f03\u30b5\u30df\u30c3\u30c8\u3067\u8a0e\u8ad6\u306e\u53f8\u4f1a\u3092\u52d9\u3081\u308b - \u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9","description":"\u5f53\u793e\u306e\u591a\u6a5f\u80fd\u30aa\u30d7\u30b7\u30f3\uff08MCO\uff09\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u306f\u3001\u81e8\u5e8a\u8a66\u9a13\u306b\u304a\u3044\u3066\u91cd\u5ea6\u306e\u8996\u529b\u55aa\u5931\u3092\u4f34\u3046\u7db2\u819c\u75be\u60a3\u60a3\u8005\u306e\u8996\u529b\u3092\u56de\u5fa9\u3055\u305b\u308b\u80fd\u529b\u3092\u5b9f\u8a3c\u3057\u305f\u521d\u306e\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u3067\u3059\u3002Nanoscope\u793e\u306f\u3001\u907a\u4f1d\u5b50\u306b\u4f9d\u5b58\u3057\u306a\u3044\u3001\u5e83\u7bc4\u56f2\u306e\u30b9\u30da\u30af\u30c8\u30eb\u3001\u9ad8\u901f\u5fdc\u7b54\u6027\u3001\u8d85\u9ad8\u611f\u5ea6\u3092\u5099\u3048\u305f\u3001\u8996\u529b\u56de\u5fa9\u306e\u305f\u3081\u306e\u6700\u521d\u3067\u552f\u4e00\u306e\u5149\u907a\u4f1d\u5b66\u6280\u8853\u3067\u3042\u308bMCO-010\u3092\u958b\u767a\u3057\u307e\u3057\u305f\u3002.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/nanostherapeutics.com\/ja\/2024\/02\/14\/nanoscope-to-moderate-discussions-at-the-4th-annual-gene-therapy-comparability-summit\/","og_locale":"ja_JP","og_type":"article","og_title":"Nanoscope to Moderate Discussions at the 4th Annual Gene Therapy Comparability Summit - Nanoscope Therapeutics","og_description":"Our multi-characteristic opsin (MCO) platform is the first to demonstrate an ability to restore vision to retinal disease patients with severe vision loss in clincial trials. Nanoscope has developed MCO-010, the first and only broad spectrum, fast response and ultra-sensitive optogenetic technology for vision restoration that is gene-agnostic.","og_url":"https:\/\/nanostherapeutics.com\/ja\/2024\/02\/14\/nanoscope-to-moderate-discussions-at-the-4th-annual-gene-therapy-comparability-summit\/","og_site_name":"Nanoscope Therapeutics","article_published_time":"2024-02-14T12:05:08+00:00","article_modified_time":"2025-06-27T16:21:28+00:00","og_image":[{"width":1200,"height":1200,"url":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2024\/02\/NSCOPE_LI_GeneTherapyComparability.jpg","type":"image\/jpeg"}],"author":"Nanoscope Therapeutics","twitter_card":"summary_large_image","twitter_image":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2024\/02\/NSCOPE_LI_GeneTherapyComparability.jpg","twitter_creator":"@NSTherapeutics","twitter_site":"@NSTherapeutics","twitter_misc":{"\u57f7\u7b46\u8005":"Nanoscope Therapeutics","\u63a8\u5b9a\u8aad\u307f\u53d6\u308a\u6642\u9593":"2\u5206"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/nanostherapeutics.com\/2024\/02\/14\/nanoscope-to-moderate-discussions-at-the-4th-annual-gene-therapy-comparability-summit\/#article","isPartOf":{"@id":"https:\/\/nanostherapeutics.com\/2024\/02\/14\/nanoscope-to-moderate-discussions-at-the-4th-annual-gene-therapy-comparability-summit\/"},"author":{"name":"Nanoscope Therapeutics","@id":"https:\/\/nanostherapeutics.com\/#\/schema\/person\/5aeedc9aef0946fe8f96f98f7b1808a2"},"headline":"Nanoscope to Moderate Discussions at the 4th Annual Gene Therapy Comparability Summit","datePublished":"2024-02-14T12:05:08+00:00","dateModified":"2025-06-27T16:21:28+00:00","mainEntityOfPage":{"@id":"https:\/\/nanostherapeutics.com\/2024\/02\/14\/nanoscope-to-moderate-discussions-at-the-4th-annual-gene-therapy-comparability-summit\/"},"wordCount":327,"publisher":{"@id":"https:\/\/nanostherapeutics.com\/#organization"},"image":{"@id":"https:\/\/nanostherapeutics.com\/2024\/02\/14\/nanoscope-to-moderate-discussions-at-the-4th-annual-gene-therapy-comparability-summit\/#primaryimage"},"thumbnailUrl":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2024\/02\/NSCOPE_LI_GeneTherapyComparability.jpg","articleSection":["Home Page","Nanoscope Press Release"],"inLanguage":"ja"},{"@type":"WebPage","@id":"https:\/\/nanostherapeutics.com\/2024\/02\/14\/nanoscope-to-moderate-discussions-at-the-4th-annual-gene-therapy-comparability-summit\/","url":"https:\/\/nanostherapeutics.com\/2024\/02\/14\/nanoscope-to-moderate-discussions-at-the-4th-annual-gene-therapy-comparability-summit\/","name":"\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u793e\u3001\u7b2c4\u56de\u907a\u4f1d\u5b50\u6cbb\u7642\u6bd4\u8f03\u30b5\u30df\u30c3\u30c8\u3067\u8a0e\u8ad6\u306e\u53f8\u4f1a\u3092\u52d9\u3081\u308b - \u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9","isPartOf":{"@id":"https:\/\/nanostherapeutics.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/nanostherapeutics.com\/2024\/02\/14\/nanoscope-to-moderate-discussions-at-the-4th-annual-gene-therapy-comparability-summit\/#primaryimage"},"image":{"@id":"https:\/\/nanostherapeutics.com\/2024\/02\/14\/nanoscope-to-moderate-discussions-at-the-4th-annual-gene-therapy-comparability-summit\/#primaryimage"},"thumbnailUrl":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2024\/02\/NSCOPE_LI_GeneTherapyComparability.jpg","datePublished":"2024-02-14T12:05:08+00:00","dateModified":"2025-06-27T16:21:28+00:00","description":"\u5f53\u793e\u306e\u591a\u6a5f\u80fd\u30aa\u30d7\u30b7\u30f3\uff08MCO\uff09\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u306f\u3001\u81e8\u5e8a\u8a66\u9a13\u306b\u304a\u3044\u3066\u91cd\u5ea6\u306e\u8996\u529b\u55aa\u5931\u3092\u4f34\u3046\u7db2\u819c\u75be\u60a3\u60a3\u8005\u306e\u8996\u529b\u3092\u56de\u5fa9\u3055\u305b\u308b\u80fd\u529b\u3092\u5b9f\u8a3c\u3057\u305f\u521d\u306e\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u3067\u3059\u3002Nanoscope\u793e\u306f\u3001\u907a\u4f1d\u5b50\u306b\u4f9d\u5b58\u3057\u306a\u3044\u3001\u5e83\u7bc4\u56f2\u306e\u30b9\u30da\u30af\u30c8\u30eb\u3001\u9ad8\u901f\u5fdc\u7b54\u6027\u3001\u8d85\u9ad8\u611f\u5ea6\u3092\u5099\u3048\u305f\u3001\u8996\u529b\u56de\u5fa9\u306e\u305f\u3081\u306e\u6700\u521d\u3067\u552f\u4e00\u306e\u5149\u907a\u4f1d\u5b66\u6280\u8853\u3067\u3042\u308bMCO-010\u3092\u958b\u767a\u3057\u307e\u3057\u305f\u3002.","breadcrumb":{"@id":"https:\/\/nanostherapeutics.com\/2024\/02\/14\/nanoscope-to-moderate-discussions-at-the-4th-annual-gene-therapy-comparability-summit\/#breadcrumb"},"inLanguage":"ja","potentialAction":[{"@type":"ReadAction","target":["https:\/\/nanostherapeutics.com\/2024\/02\/14\/nanoscope-to-moderate-discussions-at-the-4th-annual-gene-therapy-comparability-summit\/"]}]},{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/nanostherapeutics.com\/2024\/02\/14\/nanoscope-to-moderate-discussions-at-the-4th-annual-gene-therapy-comparability-summit\/#primaryimage","url":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2024\/02\/NSCOPE_LI_GeneTherapyComparability.jpg","contentUrl":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2024\/02\/NSCOPE_LI_GeneTherapyComparability.jpg","width":1200,"height":1200},{"@type":"BreadcrumbList","@id":"https:\/\/nanostherapeutics.com\/2024\/02\/14\/nanoscope-to-moderate-discussions-at-the-4th-annual-gene-therapy-comparability-summit\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/nanostherapeutics.com\/"},{"@type":"ListItem","position":2,"name":"Nanoscope to Moderate Discussions at the 4th Annual Gene Therapy Comparability Summit"}]},{"@type":"WebSite","@id":"https:\/\/nanostherapeutics.com\/#website","url":"https:\/\/nanostherapeutics.com\/","name":"\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9","description":"\u5e0c\u671b\u306e\u5149\u3092\u53d6\u308a\u623b\u3059","publisher":{"@id":"https:\/\/nanostherapeutics.com\/#organization"},"alternateName":"Nanoscope Therapeutics","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/nanostherapeutics.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"ja"},{"@type":"Organization","@id":"https:\/\/nanostherapeutics.com\/#organization","name":"\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9\u793e","alternateName":"Nanoscope Therapeutics","url":"https:\/\/nanostherapeutics.com\/","logo":{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/nanostherapeutics.com\/#\/schema\/logo\/image\/","url":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2025\/03\/NSCOPE_Logo_Stack_2Color_512.png","contentUrl":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2025\/03\/NSCOPE_Logo_Stack_2Color_512.png","width":512,"height":435,"caption":"Nanoscope Therapeutics, Inc"},"image":{"@id":"https:\/\/nanostherapeutics.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/NSTherapeutics","https:\/\/www.linkedin.com\/company\/nanoscope"]},{"@type":"Person","@id":"https:\/\/nanostherapeutics.com\/#\/schema\/person\/5aeedc9aef0946fe8f96f98f7b1808a2","name":"\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9"}]}},"_links":{"self":[{"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/posts\/5657","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/comments?post=5657"}],"version-history":[{"count":2,"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/posts\/5657\/revisions"}],"predecessor-version":[{"id":9053,"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/posts\/5657\/revisions\/9053"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/media\/5660"}],"wp:attachment":[{"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/media?parent=5657"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/categories?post=5657"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/tags?post=5657"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}